Ballenberger Freytag Wenisch - Institut für klinische Forschung
BFW-Institut conducts clinical studies and drug testing for pharmaceutical companies worldwide, with programmes in asthma, chronic bronchitis, heart disease and vaccines, plus scientific consulting and physician training.
Ballenberger Freytag Wenisch – Institut für klinische Forschung (BFW-Institut) is a clinical research institute headquartered in Germany that runs clinical studies on behalf of research-based pharmaceutical companies worldwide. Its work covers the design and conduct of clinical trials and clinical drug testing under Good Clinical Practice, alongside scientific consulting for medicine, health care and life sciences.
The institute's study portfolio spans several therapeutic areas. It conducts clinical trials of asthma medications and of treatments for chronic smoker's bronchitis, as well as studies on medicines for heart disease. Vaccination studies form a further strand of its work, carried out for global leaders in the pharmaceutical industry. Beyond trials, BFW-Institut offers scientific advisory services, disease management programmes, and seminars, courses and continuing education for physicians.
The organisation reports above-average staffing levels, a team-oriented culture and close attention to patient wellbeing and satisfaction throughout the course of its studies, with care for participants provided around the clock. It states that its measurements are carried out with the highest precision and emphasises the professional expertise of its staff. Its clients are research-based pharmaceutical companies in Germany and abroad.